AbbVie to Invest $195M in New Illinois Facility for Active Pharmaceutical Ingredients Production

martes, 12 de agosto de 2025, 6:19 pm ET1 min de lectura
ABBV--

AbbVie will invest $195 million in a new facility in North Chicago, Illinois, for the production of active pharmaceutical ingredients. The project aligns with Illinois' economic growth plan and the company's commitment to invest $10 billion in US pharmaceutical manufacturing from 2022 to 2035. The facility is expected to be completed by 2027 and will create over 300 jobs in the area.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios